Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients - Trial NCT00953914
Access comprehensive clinical trial information for NCT00953914 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital de Clinicas de Porto Alegre and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hospital de Clinicas de Porto Alegre
Timeline & Enrollment
N/A
Mar 01, 2005
May 01, 2010
Primary Outcome
autonomic modulation assessed by heart rate variability
Summary
The purpose of the study is to determine if pyridostigmine bromide improves heart rate
 variability of type 2 diabetes mellitus subjects with cardiovascular autonomic neuropathy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT00953914
Non-Device Trial